Mar 04, 2021 / 05:50PM GMT
Doug Schenkel - Cowen and Company, LLC, Research Division - MD & Senior Research Analyst
All right. Hi everybody. This is Doug Schenkel from the Cowen life science and diagnostic tools team. It's my pleasure to welcome John Nicols, President and Chief Executive Officer of Codexis to the 41st Annual Cowen and Company Healthcare Conference. John, thanks for being here today.
John J. Nicols - Codexis, Inc. - President, CEO & Director
My pleasure. Appreciate it.
Doug Schenkel - Cowen and Company, LLC, Research Division - MD & Senior Research Analyst
So John's been with Codexis since 2012 and has been key to really turning around the company and positioning it for sustained growth in SynBio, building partnerships with global biopharma giants as well as in other industries. And increasingly, the company is advancing more proprietary products.
John, I thought maybe what we would do is I'd hand it over to you. You could provide a little bit of background and updates on the story. And then I'm sure we'll
Codexis Inc at Cowen Healthcare Conference (Virtual) Transcript
Feb 06, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers